Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2005
11/30/2005EP1600165A1 Medicinal use of mip-3alpha inhibitor and method of screening brain/nerve cell protective agent
11/30/2005EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle
11/30/2005EP1599732A1 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-trp (mtr1 / ltrpc5 / trpm5)
11/30/2005EP1599715A2 Autologous or homologous coagulant produced from anticoagulated whole blood
11/30/2005EP1599605A1 Screening method for genes of brewing yeast
11/30/2005EP1599601A1 Method for identification of novel virulence associated genes
11/30/2005EP1599595A2 N -acetylglucosaminyltransferase iii expression in lower eukaryotes
11/30/2005EP1599592A1 Infectious flavivirus pseudo-particles containing functional prm and/or e proteins
11/30/2005EP1599590A2 Modified low molecular weight glutenin with reduced risk to patients with celiak disease
11/30/2005EP1599581A2 Production of a live vaccine directed against influenza viruses
11/30/2005EP1599578A2 Methods for preventing gluconoylation of proteins
11/30/2005EP1599573A2 Model for studying the role of genes in tumor resistance to chemotherapy
11/30/2005EP1599572A2 Compositions and methods for cancer immunotherapy
11/30/2005EP1599500A1 Dispersing agents in nanocomposites
11/30/2005EP1599499A2 Periodic antimicrobial peptides
11/30/2005EP1599498A2 Compositions and methods for the treatment of systemic lupus erythematosis
11/30/2005EP1599497A2 Crystal structure of the ternary compelex of 14-3-3, fusicoccin, and plasma membrane atpase and methods for designing new herbicides
11/30/2005EP1599495A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
11/30/2005EP1599494A2 Restoring function to gonadotropin releasing hormone receptor mutants
11/30/2005EP1599231A2 Treatment of pain through expression of opioid receptors
11/30/2005EP1599227A2 Methods of immunomodulation in animals
11/30/2005EP1599224A1 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation
11/30/2005EP1599223A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
11/30/2005EP1599222A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant
11/30/2005EP1599213A2 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
11/30/2005EP1599173A2 Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
11/30/2005EP1599168A2 Relaxin3-gpcr135 complexes and their production and use
11/30/2005EP1599164A2 Methods for treating, preventing and detecting helicobacter infection
11/30/2005EP1565557A4 Mismatch endonucleases and methods of use
11/30/2005EP1539949A4 Nucleic acid molecules from rice encoding rar1 disease resistance proteins and uses thereof
11/30/2005EP1437937A4 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
11/30/2005EP1435775A4 Pttg knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
11/30/2005EP1430131B1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
11/30/2005EP1335932B1 Isolation of lectins
11/30/2005EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides
11/30/2005EP1301786B1 Method for the detection of apoptosis by determining cytochrome c as apoptosis-specific marker released into an extracellular medium through cellular release mechanisms
11/30/2005EP1301605B1 Nk cells activating receptors and their therapeutic and diagnostic uses
11/30/2005EP1250351B1 Methods to identify ctl epitopes of hiv
11/30/2005EP1196586B1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis
11/30/2005EP1192268B1 Nucleic acid binding of multi-zinc finger transcription factors
11/30/2005EP1192181B1 Modulation of angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor for the treatment of tumor
11/30/2005EP1185675B1 Escherichia coli strain secreting human granulocyte colony stimulating factor (g-csf)
11/30/2005EP1151108B1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
11/30/2005EP1109909B1 Grf analogs with increased biological potency
11/30/2005EP1078063B1 Basb029 polynucleotides and polypeptides from neisseria meningitis
11/30/2005EP1015890B1 Recombinant rabbit tissue factor based prothrombin time reagent
11/30/2005EP1012298B1 Yeast strains for the production of lactic acid
11/30/2005EP1003853B1 Methods for protein screening
11/30/2005EP0960121B1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
11/30/2005EP0951541B1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease
11/30/2005EP0936922B1 Polynucleotide vaccine formula for treating horse diseases
11/30/2005EP0935662B1 Multiple epitope fusion protein
11/30/2005EP0891377B1 Inhibitor and stimulator of haematopoietic stem cell proliferation and uses thereof
11/30/2005EP0870828B1 Novel polypeptide originating from hemophilus paragallinarum and process for producing the same
11/30/2005EP0852623B1 Nucleic acid molecules which code for proteins which mediate the adhesion of neisseria cells to human cells
11/30/2005EP0832230B1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
11/30/2005EP0808364B1 Human pancreatic cell lines: developments and uses
11/30/2005EP0797666B1 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase
11/30/2005CN1703524A Genes and polypeptides relating to human pancreatic cancer
11/30/2005CN1703523A Method for diagnosing prostate cancers
11/30/2005CN1703518A Method of purifying lantibiotics
11/30/2005CN1703510A Method for designing peptides
11/30/2005CN1703425A Crystallization of IGF-1
11/30/2005CN1703424A GLP-1 derivatives and transmicosal absorption preparations thereof
11/30/2005CN1703423A Antagonists il-15
11/30/2005CN1703422A Meth1 and meth2 polynucleotides and polypeptides
11/30/2005CN1703421A Process for decreasing aggregate levels of pegylated protein
11/30/2005CN1703420A Promoters exhibiting endothelial cell specificity and methods of using same
11/30/2005CN1703248A Drug for auditory dysfunction
11/30/2005CN1703247A Anti-neovasculature preparations for cancer
11/30/2005CN1703238A Recombinant intracellular pathogen immunogenic compositions and methods for use
11/30/2005CN1703221A 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity
11/30/2005CN1702083A Antibacterial peptide DC and its preparing process and use
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1701788A Avian polynucleotide vaccine formula
11/30/2005CN1229646C Catalytic anti-factor VIII allo-antibodies
11/30/2005CN1229501C Mixture of recombinant vaccinia vectors as poly-envelope protein vaccines for HIV
11/30/2005CN1229498C Recombinant ribonuclease proteins
11/30/2005CN1229496C Method and compositions for inducing tumor-specific cytotoxicity
11/30/2005CN1229493C Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
11/30/2005CN1229391C Antibody of human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin
11/30/2005CN1229390C Peptides that lower blood glucose levels
11/30/2005CN1229389C Immunization magnetic separation technology for purifying genetic engineering recombinant interferon
11/30/2005CN1229388C N-terminal modified protein compositions and methods therefor
11/30/2005CN1229387C Novel human protein with cancer-suppressing function and coding sequence thereof
11/30/2005CN1229386C Novel human protein with function for suppressing cancer and coding sequence thereof
11/30/2005CN1229385C Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/30/2005CN1229138C Method for accelerating rate of mucociliary clearance
11/30/2005CN1229137C New therapeutic uses of SMR1 peptides
11/29/2005US6969788 Inbred maize line PHBAB
11/29/2005US6969763 Molecular interaction sites of interleukin-2 RNA and methods of modulating the same
11/29/2005US6969758 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors
11/29/2005US6969616 Compound having a log P (P denotes a partition coefficient in an octanol-water system) value of not less than 2.50 as immobilized on a water-insoluble carrier.
11/29/2005US6969609 nucleic acid sequences encoding a combination of B7, ICAM-1 and LFA-3, wherein expression of the nucleic acid sequences occurs in the host cel
11/29/2005US6969599 Nucleic acids encoding tumor necrosis factor receptor TR10
11/29/2005US6969598 Methods for producing high titre vectors and compositions used in such methods
11/29/2005US6969597 Nucleic acids encoding non aggregating fluorescent proteins and methods for using the same
11/29/2005US6969596 Polynucleotide encoding a human receptor tyrosine kinase
11/29/2005US6969588 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
11/29/2005US6969585 Universal collection medium
1 ... 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 ... 2916